Vesper Bio ApS: Financial statements 2014
CVR: 32879861
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -6,940,347 compared with DKK -2,554,127 the year before. Equity in the 2014 report amounted to DKK 5,634,281. The solvency ratio was 90%.
- Profit/Loss
- DKK -6,940,347
- Equity
- DKK 5,634,281
- Total Assets
- DKK 6,262,513
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -6.9 mio. | 5.6 mio. | - |
| 2013 | - | - | -2.6 mio. | 12.6 mio. | - |
| 2012 | - | -22 t. | -16 t. | 377 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Vesper Bio ApS has published its annual report for 2013. The net result was DKK -2,554,127.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.